CannBioRx Accounts Payable vs Non Current Assets Total Analysis

ATNFW Stock  USD 0.01  0  22.64%   
CannBioRx Life financial indicator trend analysis is way more than just evaluating CannBioRx Life Sciences prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether CannBioRx Life Sciences is a good investment. Please check the relationship between CannBioRx Life Accounts Payable and its Non Current Assets Total accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CannBioRx Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.

Accounts Payable vs Non Current Assets Total

Accounts Payable vs Non Current Assets Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of CannBioRx Life Sciences Accounts Payable account and Non Current Assets Total. At this time, the significance of the direction appears to have weak relationship.
The correlation between CannBioRx Life's Accounts Payable and Non Current Assets Total is 0.35. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of CannBioRx Life Sciences, assuming nothing else is changed. The correlation between historical values of CannBioRx Life's Accounts Payable and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of CannBioRx Life Sciences are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Accounts Payable i.e., CannBioRx Life's Accounts Payable and Non Current Assets Total go up and down completely randomly.

Correlation Coefficient

0.35
Relationship DirectionPositive 
Relationship StrengthVery Weak

Accounts Payable

An accounting item on the balance sheet that represents CannBioRx Life obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of CannBioRx Life Sciences are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.
Most indicators from CannBioRx Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CannBioRx Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CannBioRx Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
Selling General Administrative is likely to drop to about 7.6 M in 2024. Tax Provision is likely to climb to about (3.1 M) in 2024
 2021 2022 2023 2024 (projected)
Research Development3.9M2.4M2.8M2.7M
Depreciation And Amortization116.3K109.0K105.7K101.1K

CannBioRx Life fundamental ratios Correlations

0.250.430.090.870.690.440.130.880.850.280.030.080.05-0.080.17-0.080.220.030.130.10.220.240.220.340.07
0.250.84-0.52-0.210.570.970.720.52-0.250.89-0.170.62-0.61-0.820.64-0.8-0.20.75-0.30.080.86-0.11-0.140.680.75
0.430.84-0.24-0.070.530.910.550.63-0.10.78-0.050.47-0.37-0.640.41-0.640.140.55-0.060.030.660.180.230.670.48
0.09-0.52-0.240.25-0.63-0.42-0.72-0.180.29-0.370.39-0.670.980.89-0.10.890.89-0.940.910.45-0.420.890.70.22-0.8
0.87-0.21-0.070.250.46-0.04-0.150.61.0-0.130.03-0.160.270.28-0.110.290.19-0.280.180.04-0.150.170.14-0.02-0.2
0.690.570.53-0.630.460.650.560.830.420.43-0.150.46-0.68-0.710.24-0.71-0.460.71-0.51-0.170.43-0.44-0.30.080.56
0.440.970.91-0.42-0.040.650.690.65-0.080.88-0.160.59-0.52-0.760.64-0.74-0.060.67-0.220.110.850.00.040.720.68
0.130.720.55-0.72-0.150.560.690.22-0.220.8-0.770.99-0.71-0.810.15-0.76-0.370.78-0.74-0.520.78-0.47-0.180.290.92
0.880.520.63-0.180.60.830.650.220.590.340.220.11-0.29-0.420.43-0.43-0.020.370.030.250.380.040.010.330.18
0.85-0.25-0.10.291.00.42-0.08-0.220.59-0.180.08-0.220.310.32-0.110.320.2-0.320.220.07-0.20.190.14-0.04-0.25
0.280.890.78-0.37-0.130.430.880.80.34-0.18-0.470.75-0.4-0.630.4-0.59-0.020.56-0.31-0.180.820.050.050.780.81
0.03-0.17-0.050.390.03-0.15-0.16-0.770.220.08-0.47-0.850.280.290.290.220.17-0.30.650.73-0.430.360.02-0.04-0.66
0.080.620.47-0.67-0.160.460.590.990.11-0.220.75-0.85-0.64-0.720.05-0.67-0.320.7-0.73-0.580.75-0.46-0.150.240.88
0.05-0.61-0.370.980.27-0.68-0.52-0.71-0.290.31-0.40.28-0.640.94-0.190.950.83-0.980.840.35-0.470.830.640.15-0.76
-0.08-0.82-0.640.890.28-0.71-0.76-0.81-0.420.32-0.630.29-0.720.94-0.360.990.62-0.990.710.24-0.680.610.43-0.15-0.82
0.170.640.41-0.1-0.110.240.640.150.43-0.110.40.290.05-0.19-0.36-0.340.080.260.210.760.660.130.080.610.17
-0.08-0.8-0.640.890.29-0.71-0.74-0.76-0.430.32-0.590.22-0.670.950.99-0.340.64-0.990.690.23-0.620.610.46-0.12-0.78
0.22-0.20.140.890.19-0.46-0.06-0.37-0.020.2-0.020.17-0.320.830.620.080.64-0.720.820.41-0.020.910.910.49-0.56
0.030.750.55-0.94-0.280.710.670.780.37-0.320.56-0.30.7-0.98-0.990.26-0.99-0.72-0.78-0.320.58-0.7-0.540.030.82
0.13-0.3-0.060.910.18-0.51-0.22-0.740.030.22-0.310.65-0.730.840.710.210.690.82-0.780.72-0.270.880.580.33-0.79
0.10.080.030.450.04-0.170.11-0.520.250.07-0.180.73-0.580.350.240.760.230.41-0.320.720.10.470.280.35-0.5
0.220.860.66-0.42-0.150.430.850.780.38-0.20.82-0.430.75-0.47-0.680.66-0.62-0.020.58-0.270.1-0.110.060.640.68
0.24-0.110.180.890.17-0.440.0-0.470.040.190.050.36-0.460.830.610.130.610.91-0.70.880.47-0.110.740.61-0.51
0.22-0.140.230.70.14-0.30.04-0.180.010.140.050.02-0.150.640.430.080.460.91-0.540.580.280.060.740.43-0.42
0.340.680.670.22-0.020.080.720.290.33-0.040.78-0.040.240.15-0.150.61-0.120.490.030.330.350.640.610.430.3
0.070.750.48-0.8-0.20.560.680.920.18-0.250.81-0.660.88-0.76-0.820.17-0.78-0.560.82-0.79-0.50.68-0.51-0.420.3
Click cells to compare fundamentals

CannBioRx Life Account Relationship Matchups

CannBioRx Life fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets51.9M55.5M62.7M19.7M5.3M5.0M
Total Current Liabilities9.6M21.4M19.7M5.7M5.1M8.6M
Total Stockholder Equity38.6M30.3M39.3M11.3M(127.7K)(121.3K)
Retained Earnings(37.5M)(48.4M)(68.7M)(107.4M)(127.3M)(121.0M)
Cash And Short Term Investments83.4K2.1M8.2M7.0M2.0M1.9M
Total Liab13.3M25.2M23.4M8.3M5.4M5.1M
Total Current Assets748.3K4.0M11.2M8.9M3.6M4.0M
Common Stock1.4K2.6K3.4K375.054.051.3
Other Current Liab2.0M9.2M17.2M2.5M1.9M1.8M
Net Debt3.4M1.7M(6.3M)(5.6M)(921.7K)(967.8K)
Cash83.4K2.1M8.2M7.0M2.0M3.2M
Non Current Assets Total51.1M51.5M51.5M10.7M1.6M1.5M
Common Stock Shares Outstanding29.0K26.2M82.5K100.0K379.1K360.1K
Liabilities And Stockholders Equity51.9M55.5M62.7M19.7M5.3M5.0M
Non Current Liabilities Total3.7M3.8M3.7M2.6M324.6K308.4K
Other Stockholder Equity75.9M78.0M107.2M121.6M130.1M136.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for CannBioRx Stock Analysis

When running CannBioRx Life's price analysis, check to measure CannBioRx Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannBioRx Life is operating at the current time. Most of CannBioRx Life's value examination focuses on studying past and present price action to predict the probability of CannBioRx Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannBioRx Life's price. Additionally, you may evaluate how the addition of CannBioRx Life to your portfolios can decrease your overall portfolio volatility.